Opioid use and harms associated with a sustained-release tapentadol formulation: a postmarketing study protocol

INTRODUCTION: It has been argued that tapentadol may pharmacologically have lower abuse potential than other pharmaceutical opioids currently available. However, there has been no comprehensive triangulation of data regarding use and harms associated with this formulation. A sustained-release formul...

Descripción completa

Detalles Bibliográficos
Autores principales: Peacock, Amy, Larance, Briony, Farrell, Michael, Cairns, Rose, Buckley, Nicholas, Degenhardt, Louisa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2018
Materias:
Addiction
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5875643/
https://www.ncbi.nlm.nih.gov/pubmed/29574444
http://dx.doi.org/10.1136/bmjopen-2017-020006

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5875643/
https://www.ncbi.nlm.nih.gov/pubmed/29574444
http://dx.doi.org/10.1136/bmjopen-2017-020006

Ejemplares similares